These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23726405)

  • 21. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism.
    Magee G; Peters C; Zbrozek A
    Clin Ther; 2013 Sep; 35(9):1432-43. PubMed ID: 23954093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma: indications, controversies, and opportunities.
    Benson MA; Tolich D; Callum JL; Auron M
    Postgrad Med; 2024 Mar; 136(2):120-130. PubMed ID: 38362605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elective fresh frozen plasma in the critically ill: what is the evidence?
    Verghese SG
    Crit Care Resusc; 2008 Sep; 10(3):264-8. PubMed ID: 18798728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results.
    Holland LL; Brooks JP
    Am J Clin Pathol; 2006 Jul; 126(1):133-9. PubMed ID: 16753596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant.
    O'Shaughnessy DF; Atterbury C; Bolton Maggs P; Murphy M; Thomas D; Yates S; Williamson LM;
    Br J Haematol; 2004 Jul; 126(1):11-28. PubMed ID: 15198728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
    Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
    Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of treatment-related fluid overload reduces estimated effective cost of prothrombin complex concentrate in patients requiring rapid vitamin K antagonist reversal.
    Jones CA; Ducis K; Petrozzino J; Clark E; Fung MK; Peters C; Sarkar IN; Krol E; Pochal B; Boutrus A; Weimersheimer P; Freeman K
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(1):135-9. PubMed ID: 26211539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What to do when warfarin therapy goes too far.
    Prasad S; Wootten MR; Kulinski N; Chapman SA
    J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can asymptomatic patients with a supratherapeutic international normalized ratio be safely treated as outpatients?
    Levine M; Ruha AM; Goldstein JN
    Ann Emerg Med; 2012 Apr; 59(4):318-20. PubMed ID: 21867663
    [No Abstract]   [Full Text] [Related]  

  • 32. Coagulation support: fresh frozen plasma versus clotting factor concentrate.
    Felfernig M; Felfernig-Böhm D; Hartmann T; Schobersberger W
    Anaesthesia; 1998 May; 53 Suppl 2():54-5. PubMed ID: 9659068
    [No Abstract]   [Full Text] [Related]  

  • 33. Treating warfarin-related intracerebral hemorrhage: is fresh frozen plasma enough?
    Hemphill JC
    Stroke; 2006 Jan; 37(1):6-7. PubMed ID: 16306461
    [No Abstract]   [Full Text] [Related]  

  • 34. A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage.
    Safaoui MN; Aazami R; Hotz H; Wilson MT; Margulies DR
    Am J Surg; 2009 Jun; 197(6):785-90. PubMed ID: 18722586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of plasma in the management of central nervous system bleeding: evidence-based consensus recommendations.
    Shander A; Michelson EA; Sarani B; Flaherty ML; Shulman IA
    Adv Ther; 2014 Jan; 31(1):66-90. PubMed ID: 24338742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus conference. Fresh-frozen plasma. Indications and risks.
    JAMA; 1985 Jan; 253(4):551-3. PubMed ID: 3968788
    [No Abstract]   [Full Text] [Related]  

  • 37. Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation.
    Mitra B; Mori A; Cameron PA; Fitzgerald M; Paul E; Street A
    Injury; 2010 Jan; 41(1):35-9. PubMed ID: 19833331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prothrombin complex concentrates used alone in urgent reversal of warfarin anticoagulation.
    Tran H; Collecutt M; Whitehead S; Salem HH
    Intern Med J; 2011 Apr; 41(4):337-43. PubMed ID: 20403070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need.
    Bolliger D; Mauermann E; Tanaka KA
    J Cardiothorac Vasc Anesth; 2015; 29(3):768-76. PubMed ID: 26009289
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical use of fresh-frozen plasma and cryoprecipitate in neonatal intensive care unit.
    Motta M; Del Vecchio A; Radicioni M
    J Matern Fetal Neonatal Med; 2011 Oct; 24 Suppl 1():129-31. PubMed ID: 21942611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.